RTTNews | Oct 19, 2020 06:48AM EDT

06:47 Monday, October 19, 2020 (RTTNews.com) - Centogene N.V. (CNTG) said the FDA has issued Emergency Use Authorization for CentoSure, the company's SARS-CoV-2 RT-PCR test. CentoSure SARS-CoV-2 RT-PCR assay is a real-time test based on the reverse transcription polymerase chain reaction for the qualitative detection of SARS-CoV-2, the virus causing COVID-19.

Arndt Rolfs, CEO of CENTOGENE, said, "This emergency use authorization by the FDA is an extremely important further step to prevent a further spread of COVID-19, specifically in countries that have been heavily impacted, like the U.S.".

Read the original article on RTTNews ( https://www.rttnews.com/3137084/centogene-fda-issues-emergency-use-authorization-for-sars-cov-2-rt-pcr-assay.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved